NovoCure Ltd (NVCR) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.22 | +21.8% |
| 2024 | $-1.56 | +20.0% |
| 2023 | $-1.95 | -121.6% |
| 2022 | $-0.88 | -57.1% |
| 2021 | $-0.56 | -411.1% |
| 2020 | $0.18 | +357.1% |
| 2019 | $-0.07 | +89.9% |
| 2018 | $-0.69 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.22 | +21.8% |
| 2024 | $-1.56 | +20.0% |
| 2023 | $-1.95 | -121.6% |
| 2022 | $-0.88 | -57.1% |
| 2021 | $-0.56 | -411.1% |
| 2020 | $0.18 | +357.1% |
| 2019 | $-0.07 | +89.9% |
| 2018 | $-0.69 | — |